Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice Les WhiteBernard C. SzirthWilliam F. Benedict Original Articles Pages: 63 - 67
Tumor and serum tamoxifen concentrations in the athymic nude mouse Michael W. DeGregorioEster CoronadoC. Kent Osborne Original Articles Pages: 68 - 70
Neurotoxicity and dermatotoxicity of cyanomorpholinyl adriamycin Steven C. CramerRoy H. RhodesZoltán A. Tökés Original Articles Pages: 71 - 75
Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma S. GeraE. MuschU. Loos Original Articles Pages: 76 - 80
Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin J. A. E. BalazsovitsL. D. MayerR. E. Falk Original Articles Pages: 81 - 86
In vitro evidence for dose-dependent cytotoxicity as the predominant effect of low dose Ara-C on human leukemic and normal marrow cells Clara S. P. ChanGeraldine P. Schechter Original Articles Pages: 87 - 94
High-dose melphalan dosage adjustment: possibility of using a test-dose Brigitte TranchandYves-Dominique PloinClaude Ardiet Original Articles Pages: 95 - 100
Prospective evaluation of chronic cardiotoxicity due to high-dose epirubicin or combination chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil H. HavsteenI. BrynjolfO. Munck Original Articles Pages: 101 - 104
Randomised trial comparing prednimustine with combination chemotherapy in advanced ovarian carcinoma Robert C. F. LeonardGeorge E. SmartJohn F. Smyth Original Articles Pages: 105 - 110
The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids J. RussellJ. AdamS. B. Kaye Original Articles Pages: 111 - 114
Mitomycin C treatment of advanced, hormone-resistant prostatic carcinoma: a phase II study A. VeronesiV. Dal BoS. Monfardini Original Articles Pages: 115 - 116
Enhanced cutaneous radiation effects following high-dose busulfan therapy G. VassalO. HartmannJ. Lemerle Original Articles Pages: 117 - 118
A new anticancer agent (LY186641) interferes with creatinine assay Marc M. BonnayGonzalo RecondoJean-Pierre Armand Short Communication Pages: 119 - 120
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomas S. TuraP. MazzaR. Zanchini Short Communication Pages: 123 - 125
Human pharmacokinetics of carboplatin after oral administration Maaike B. van HennikWim J. F. van der VijghHerbert M. Pinedo Letter to the Editors Pages: 126 - 127
Failure of response to ifosfamide in squamous cell bronchogenic carcinoma J. BanksE. G. AndersonA. P. Smith Letter to the Editors Pages: 128 - 128